The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

Sofie Mylle; Jorien Papeleu; Isabelle Hoorens; Evelien Verhaeghe; Lieve Brochez

doi:10.2196/40053

The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

JMIR Dermatol. 2024 Feb 29:7:e40053. doi: 10.2196/40053.

Authors

Sofie Mylle^#^{1

2}, Jorien Papeleu^#^{1

2}, Isabelle Hoorens^{1

2}, Evelien Verhaeghe^{1

2}, Lieve Brochez^{1

2}

Affiliations

¹ Dermatology Department, Ghent University Hospital, Ghent, Belgium.
² Cancer Research Institute Ghent, Ghent, Belgium.

^# Contributed equally.

PMID: 38422495
PMCID: PMC10940973
DOI: 10.2196/40053

No abstract available

Keywords: EGFR-inhibitors; cancer; dermatology; e-health; epidermal growth factor receptor; oncology; pilot study; skin toxicity; teledermatology; therapy.

Publication types

Research Support, Non-U.S. Gov't